Inventors:
Roman Artymyshyn - Flemington NJ, US
Liliana Delgado - Rochelle Park NJ, US
Pierre Vaysse - Franklin Lakes NJ, US
Hong Zhang - Fort Lee NJ, US
Weinong Guo - Marietta GA, US
Assignee:
Synaptic Pharmaceutical Corporation
International Classification:
G01N033/53, G01N033/567
Abstract:
This invention provides methods of treating an abnormality that is linked to the activity of the mammalian SNORF138 receptor, as well as methods of determining binding of compounds to the mammalian SNORF138 receptor, methods of identifying agonists and antagonists of the SNORF138 receptor, and agonists and antagonists so identified.